CSL Gains Flu-Vaccine Scale With Novartis Deal: Perreault

Paul Perreault, chief executive officer for CSL Behring LLC, talks about the acquisition of Novartis AG's influenza vaccination business and growth strategy. Perreault speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Coutts’ Higgins Says Macro Beats Politics
57:52 - Coutts CIO Alan Higgins discusses uncertainty surrounding the French election, navigating political risk and the Mexican peso. He speaks with Mark Barton on "Bloomberg Markets.” (Source: Bloomberg)
  • Is Political Risk Premium Being Priced Into U.S. Assets?
  • Apple Stock Rises as Pressure Mounts to Find Growth
  • London House Prices Post Biggest Drop in Six Years